Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare Data.

ABSTRACT:

Background

Evidence suggests that high-volume facilities achieve better rectal cancer outcomes.

Methods

Logistic regression was used to evaluate association of facility type with treatment after adjusting for patient demographics, stage, and comorbidities. SEER-Medicare beneficiaries who were diagnosed with stage II/III rectal adenocarcinoma at age ≥66 years from 2005 to 2009 and had Parts A/B Medicare coverage for ≥1 year prediagnosis and postdiagnosis plus a claim for cancer-directed surgery were included. Institutions were classified according to National Cancer Institute (NCI) designation, presence of residency program, or medical school affiliation.

Results

Two thousand three hundred subjects (average age = 75) met the criteria. Greater proportions of those treat

SUBMITTER: Charlton ME 

PROVIDER: S-EPMC7332110 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature